SSW
CELG

Smith Shellnut Wilson’s Celgene Corp CELG Stock Holding History

Smith Shellnut Wilson’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,514
Closed -$262K – 142
2017
Q4 		$262K Hold
2,514
– – 0.22% 103
2017
Q3 		$367K Sell
2,514
-557
-18% -$75.9K 0.32% 68
2017
Q2 		$303K Sell
3,071
-158
-5% -$19.4K 0.31% 72
2017
Q1 		$402K Hold
3,229
– – 0.37% 58
2016
Q4 		$374K Buy
+3,229
New +$360K 0.36% 61

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Smith Shellnut Wilson's CELG Position: Q1 2018 in Review

Smith Shellnut Wilson sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,514 shares — an estimated $262K sold.

Smith Shellnut Wilson first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $402K in Q1 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Smith Shellnut Wilson reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Smith Shellnut Wilson sold 2,514 Celgene Corp shares in Q1 2018, an estimated $262K.
  • Smith Shellnut Wilson first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • Smith Shellnut Wilson's Celgene Corp position peaked at $402K in Q1 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Smith Shellnut Wilson's 13F filing for Q1 2018, filed 24 Apr 2018.